FY2028 Earnings Estimate for TriMas Issued By Zacks Research

TriMas Corporation (NASDAQ:TRS) – Analysts at Zacks Research issued their FY2028 earnings per share (EPS) estimates for shares of TriMas in a research report issued to clients and investors on Thursday, March 12th. Zacks Research analyst Team anticipates that the industrial products company will post earnings of $2.14 per share for the year. Zacks Research currently has a “Strong Sell” rating on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share.

TriMas (NASDAQ:TRS) last posted its quarterly earnings data on Thursday, February 26th. The industrial products company reported $0.40 earnings per share for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.01). TriMas had a net margin of 11.53% and a return on equity of 12.04%. The company had revenue of ($139.97) million for the quarter, compared to the consensus estimate of $192.96 million. During the same period last year, the business earned $0.43 EPS. The firm’s quarterly revenue was up 12.4% on a year-over-year basis.

Other analysts have also issued research reports about the company. BWS Financial restated a “buy” rating and set a $45.00 price target on shares of TriMas in a report on Monday, March 2nd. KeyCorp reaffirmed an “overweight” rating and set a $38.00 price objective on shares of TriMas in a research note on Thursday, February 26th. Weiss Ratings reiterated a “hold (c+)” rating on shares of TriMas in a research report on Monday, December 29th. Finally, Wall Street Zen downgraded shares of TriMas from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $41.50.

TriMas Price Performance

Shares of NASDAQ:TRS opened at $35.04 on Friday. The company has a market capitalization of $1.32 billion, a PE ratio of 11.80 and a beta of 0.55. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.52 and a quick ratio of 1.93. The business has a fifty day moving average price of $35.94 and a 200-day moving average price of $35.99. TriMas has a 1-year low of $19.45 and a 1-year high of $42.00.

Institutional Investors Weigh In On TriMas

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in TriMas by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,120 shares of the industrial products company’s stock worth $565,000 after acquiring an additional 1,014 shares in the last quarter. Jane Street Group LLC purchased a new position in shares of TriMas during the first quarter worth approximately $868,000. AE Wealth Management LLC bought a new stake in shares of TriMas during the second quarter valued at approximately $212,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of TriMas in the second quarter valued at approximately $230,000. Finally, LSV Asset Management purchased a new stake in shares of TriMas in the second quarter valued at approximately $498,000. Institutional investors own 99.42% of the company’s stock.

TriMas Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 27th were issued a $0.04 dividend. The ex-dividend date was Friday, February 27th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.5%. TriMas’s dividend payout ratio is presently 5.39%.

Key Stories Impacting TriMas

Here are the key news stories impacting TriMas this week:

• Neutral Sentiment: Zacks published a FY2028 estimate of $2.14 per share for TRS (a modest step above its FY2027 view), but the firm still carries a “Strong Sell” rating. This is forward-looking and may carry mixed implications for investors. Read More.
• Negative Sentiment: Zacks sharply reduced FY2026 and FY2027 EPS forecasts and cut multiple quarterly estimates — e.g., FY2026 lowered to $1.59 from $2.50, FY2027 to $2.08 from $2.54. Major quarterly downgrades include Q1 2026 to $0.18 (from $0.54), Q2 2026 to $0.47 (from $0.73), Q3 2026 to $0.54 (from $0.69), and Q4 2026 to $0.40 (from $0.54). These across-the-board reductions suggest Zacks expects weaker near-term performance and are pressuring the stock. Read More.
• Negative Sentiment: Zacks also cut several 2027 quarterly estimates (Q1 2027 to $0.32 from $0.56; Q2 2027 to $0.59 from $0.72; Q3 2027 to $0.65 from $0.66; Q4 2027 to $0.52 from $0.60), signaling a downgraded growth trajectory next fiscal year. The repeated “Strong Sell” stance increases downside sentiment among investors. Read More.

TriMas Company Profile

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.